TrialCancer chemotherapy and pharmacology2018

A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients.

Tetsuya Hamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.